The Utility of Extravascular Lung Water Measurements Following Bilateral Lung Transplant

Similar documents
Extravascular lung water reflects pulmonary edema F Javier Belda MD, PhD Dept. Anesthesiology and Critical Care

The Association Between Oxygenation Thresholds and Mortality During Extracorporeal Life Support

Marcelo Cypel MD MSc

Refresher Course. European Society of Anaesthesiologists BEDSIDE MEASUREMENT OF EXTRA-VASCULAR LUNG WATER TECHNIQUE AND CLINICAL IMPLICATIONS 12 RC 9

Outcomes From Severe ARDS Managed Without ECMO. Roy Brower, MD Johns Hopkins University Critical Care Canada Forum Toronto November 1, 2016

Indications for prolongation of ECMO into the early postoperative period in lung transplantation How we do it

Frequently asked questions and answers:

How to apply advanced hemodynamic parameters in the ICU 奇美醫學中心

Optimizing the Donor Lung with EVLP

PCV and PAOP Old habits die hard!

Transpulmonary thermodilution in septic shock & ARDS

Oxygen:..Nothing is without poison.. the poison is in the dose..

Functional Hemodynamic Monitoring and Management A practical Approach

Managing an Organ - New Therapies

ECLS as Bridge to Transplant

ECMO vs. CPB for Intraoperative Support: How do you Choose?

ECLS Bridge to Lung Transplantation Optimizing and Ambulating the Recipient

PiCCO technology. Hemodynamic monitoring at the highest level

Oregon Health and Science University Portland, Oregon USA

Extracorporeal membrane oxygenation after lung transplantation: risk factors and outcomes analysis

Fluid responsiveness and extravascular lung water

Wet Lungs Dry lungs Impact on Outcome in ARDS. Charlie Phillips MD Division of PCCM OHSU 2009

The new ARDS definitions: what does it mean?

Rounds in the ICU. Eran Segal, MD Director General ICU Sheba Medical Center

PulsioFlex Patient focused flexibility

CARDIAC OUTPUT Monitoring ANDY CAMPBELL JOURNAL CLUB NOV 2011

Hemodynamic monitoring beyond cardiac output

Landmark articles on ventilation

NIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

ARDS Assisted ventilation and prone position. ICU Fellowship Training Radboudumc

Best of Pulmonary Jennifer R. Hucks, MD University of South Carolina School of Medicine

Review Article Extravascular Lung Water and Acute Lung Injury

ACUTE RESPIRATORY DISTRESS SYNDROME

Ventilator ECMO Interactions

Adult Extracorporeal Life Support (ECLS)

How can the PiCCO improve protocolized care?

06/04/2013 ISHLT. 2 International Conference on Respiratory Physiotherapy ARIR Genova, March 21 23, 2013

Year in Review: Critical Care Medicine

Veno-Venous ECMO Support. Chris Cropsey, MD Sept. 21, 2015

PATIENT CHARACTERISTICS AND PREOPERATIVE DATA (ecrf 1).

ECMO: a breakthrough in care for respiratory failure. PD Dr. Thomas Müller Regensburg no conflict of interest

ECMO and refractory Hypoxemia

Management of Severe ARDS: Current Canadian Practice

5/15/2018. Background. Disclosure Statement

Biomarkers for ARDS not so simple. John Laffey. Critical Illness and Injury Research Centre St Michael s Hospital, University of Toronto, CANADA

Cardiac Output Monitoring - 6

Breathing life into new therapies: Updates on treatment for severe respiratory failure. Whitney Gannon, MSN ACNP-BC

Supplementary Appendix

TIMING FOR TRANSPLANT: ARE WE ALWAYS LATE?

Effects of mechanical ventilation on organ function. Masterclass ICU nurses

Maximizing Donor Lungs: Push and Mend. Amy Pope-Harman, MD. Klassen Research Day. January 22, 2015

Is ARDS Important to Recognize?

What s New About Proning?

Difficult Ventilation in ARDS Patients

Index. Note: Page numbers of article titles are in boldface type

Definition- study of blood flow Haemodynamic monitoring refers to monitoring of blood in the cardiovascular system Uses Is NB in the critically ill

The GOLD Study. Goal of Open Lung Ventilation in Donors. Michael A. Matthay M.D. and Lorraine B. Ware, MD. Disclosures

University Health Network Scholarly List

BASIC CRITICAL CARE OF THE PATIENT. Hannelisa Callisen PA C February 2017

Recent advance of lung water measurement and clinical implications

Common pitfalls and tips and tricks to get the most out of your transpulmonary thermodilution device: results of a survey and state-of-the-art review

ARDS and treatment strategies

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv

Canadian Trauma Trials Collaborative. Occult Pneumothorax in Critical Care (OPTICC): Standardized Data Collection Sheet

Inhaled nitric oxide: clinical evidence for use in adults

ICU management and referral guidelines for severe hypoxic respiratory failure

Increased female mortality after ICU admission and its potential causes.

CASE PRESENTATION VV ECMO

Reverse (fluid) resuscitation Should we be doing it? NAHLA IRTIZA ISMAIL

Regulatory Realities Redefining Benefit of Lung Transplant in the Current Era

Acute Respiratory Distress Syndrome in Immunocompromised Patients

Management of refractory ARDS. Saurabh maji

Management of a Patient after the Bidirectional Glenn

Pulse Contour Analysis and Transpulmonary Thermodilution

OLB (Open Lung Biopsy) in ARDS

Surgery Grand Rounds. Non-invasive Ventilation: A valuable tool. James Cromie, PGY 3 8/24/09

PREVENT COMPLICATIONS IN MAJOR SURGERY

Mechanical ventilation induced or exacerbated right ventricular failure

ECMO for Severe Hypoxemic Respiratory Failure: Pro-Con Debate. Carolyn Calfee, MD MAS Mark Eisner, MD MPH

MANAGEMENT OF LATE PRESENTATION OF CONGENITAL HEART DESEASE

Monitoring lung edema

ARDS: The Evidence. Topics. New definition Breaths: Little or Big? Wet or Dry? Moving or Still? Upside down or Right side up?

NIV in hypoxemic patients

THE ACUTE RESPIRATORY DISTRESS SYNDROME. Daniel Brockman, DO

Experience with the first 50 ex vivo lung perfusions in clinical transplantation

In Vivo Lung Perfusion (IVLP) for Cancer Therapy and Gene Therapy of the Lung

Oxygenation Failure. Increase FiO2. Titrate end-expiratory pressure. Adjust duty cycle to increase MAP. Patient Positioning. Inhaled Vasodilators

Lung Allograft Dysfunction

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD

ARDS: an update 6 th March A. Hakeem Al Hashim, MD, FRCP SQUH

Changing Demographics in Death After Devastating Brain Injury

Topics to Cover. Post-op Management of Heart and Lung Transplants. Graft Dysfunction (Heart) Hemodynamic Instability. Hemodynamic Instability

Optimal Intraoperative support

Immediate pulmonary dysfunction in ischemic heart disease patients undergoing off-pump versus on-pump CABG

Single-lung transplantation in the setting of aborted bilateral lung transplantation

Acute Respiratory Distress Syndrome (ARDS) An Update

Application of Lung Protective Ventilation MUST Begin Immediately After Intubation

What is the Role of Albumin in Sepsis? An Evidenced Based Affair. Justin Belsky MD PGY3 2/6/14

Who and When to Refer for a Heart Transplant

Transcription:

The Utility of Extravascular Lung Water Measurements Following Bilateral Lung Transplant Laveena Munshi, MD, MSc November 2018 Interdepartmental Division of Critical Care Medicine Mount Sinai Hospital/University Health Network University of Toronto Toronto, Canada

Disclosures Ontario Thoracic Society Grant No Relevant Financial Disclosures

Pulmonary Edema Remains the Hallmark of ARDS The accurate detection and quantification of pulmonary edema has important clinical implications

Methods of estimating pulmonary edema and/or volume status are numerous but fraught with error Extravascular Lung Water Intravascular Volume Status

Objectives Transpulmonary thermodilution and extravascular lung water Evolution of evidence surrounding extravascular lung water The utility of extravascular lung water following bilateral lung transplant

Transpulmonary Thermodilution: Extravascular Lung Water Mean Transit Time Cardiac Output Down slope time Extravascular Lung Water Global End Diastolic Volume Pulmonary Vascular Permeability Index

EVLW 10 cc/kg Associated with Clinically Significant Pulmonary Edema 7

The Evidence: Validation 8

The Evidence: EVLW Distinguishes Between Causes of Acute Respiratory Failure 9

10

Acute Respiratory Failure Following Lung Transplant is Not Uncommon PRIMARY GRAFT DYSFUNCTION Severed Lymphatics During Transplant 11

Diffuse Pulmonary Infiltrates in 72 hours Post Lung Transplant: Primary Graft Dysfunction (PGD) Utility of PGD classification Lack precise methods to predict development and prognosticate outcome Diffuse pulmonary infiltrates in first 72 hours following Emerging transplant Utility of Grade 1 PGD (PaO 2 EVLW /FiO 2 ratio >300) Grade 2 PGD (PaO 2 /FiO 2 200-300) Grade 3 PGD (PaO 2 /FiO 2 <200) Pulmonary edema Evaluated at time 0, 24 hours, 48 hours, 72 hours following transplant may be more challenging to Incidence manage of grade post 3 PGD LTx at any time point after transplant ~30% Associated PGD with classification increased LOS, mortality and BOS issues with and later inability scores correlating better with to outcomes predict PGD 12 Diamond et al The Journal of Heart and Lung Transplant 2017

The Utility of Extravascular Lung Water Following Bilateral Lung Transplant 13

OBJECTIVES AIM 1: Evaluate the association between EVLW and PGD PGD 1 AIM 2: Evaluate whether early measurements of EVLW are associated with greater severities of PGD at later time points AIM 3: Evaluate whether early EVLW is associated with duration of mechanical ventilation independent of PGD T X EVL W PGD PGD PGD PGD 2 PGD 3 14

METHODS Prospective observational study of all adult consecutive bilateral lung transplant at TGH Exclusion Criteria: Immediate need for post operative ECMO, contraindication to femoral arterial catheterization, single lung transplant instead of double Transpulmonary Thermodilution (EVLW) 0 6 12 24 36 48 60 72 Goal: 56 patients 30% incidence of higher grade PGD/3cc/kg EVLW difference Outcomes PGD Determination 2 independent reviewers Evaluated at times 0, 24, 48, 72 hours Grades 0/1 classified as grade 1 All extubated patients classified as grade 1 Duration of Mechanical Ventilation

Patient and Donor Details Age 55 (SD 11) Sex Transplant indication Donor 36 No 58% Male 56 Maybe 35% IPF 31% COPD/Emphysema 11% CF 24% Other 82% NDD Donor Age 48 (SD 19) Donor Smoking Donor Duration of MV EVLP 25% 44% Yes 54% No 2% Unknown 2 (IQR 1-3) 31 patients excluded 229 Patients Approached 137 Consented 87 Called for Transplant 56 Patients Included 268 TPTD measurements 220 PGD determinations IntraOR Support Blood Transfusion Total Ischemic Time (min) OR and ICU Details 44% ECLS 4% CPB 47% 1215 (SD 430) APACHE II 17 (SD 4) Pa02/FiO2 355 (240-445) ino 42% Duration of MV MV >48hrs 44% 2 (1-5) days

Low Incidence of Grade 3 PGD 25% had a deterioration in PGD grade over this time period

Grade 3 PGD Associated with Longer Duration of Mechanical Ventilation Median Duration of Mechanical Ventilation (days) 8 7 6 5 4 3 2 1 0 PGD 1 PGD 2 PGD 3 Grade 1 PGD Grade2 PGD at Grade 3 PGD at admission admission at admission DurMV 2 days (1-3) 2 day (1-9) 8 days (3-24)

PaO 18 2 /FiO 2 <200 strong correlation with increase in EVLW 16 14 15 12 10 8 9 9 9 11 Correlation between EVLW and PF <200 Spearman s Rho -0.64, p=0.001 6 4 2 ELWI LCI UCI 0 P/F>400 P/F 300-400 P/F 200-300 P/F 100-200 P/F <100 Worsening Severity of Graft Dysfunction

EVLW but not PVPI was associated with PGD Grade Median EVLW across PGD (cc/kg) Median PVPI across PGD 14 12 10 8 6 4 2 0 PGD 1 PGD 2 PGD 3 3 2.8 2.6 2.4 2.2 2 1.8 1.6 1.4 1.2 1 PGD 1 PGD 2 PGD 3 Grade 1 PGD Grade2 PGD Grade 3 PGD EVLW 9 (8-11) 10 (8-12) 12 (9-15) p <0.001 PVPI 1.7 (1.5-2.4) Grade 1 PGD Grade2 PGD Grade 3 PGD 1.8 (1.3-2.0) p=0.067 2.1 (1.9-2.7)

Within strata of higher grade PGD at 24 hours high/low EVLW yielded different durations of MV PGD 1 PaO 2 /FiO 2 >300 EVLW low ( 8) EVLW high (>8) PGD 2 PaO 2 /FiO 2 200-300 EVLW low ( 9) EVLW high (>9) PGD 3 PaO 2 /FiO 2 <200 EVLW low ( 12) EVLW high (>12) PF 341 (333-360) PF 360 (320-400) PF 263 (225-273) PF 222 (214 226) PF 186 (180-193) PF 144 (99-190) Duration of Mechanical Ventilation 2 (1-3) days 1 (1-2) days 4 (3-11) days 14 (3-23) days 3 (3-33) days 30 (4-55) days

Prediction of PGD at 24 hours based upon early EVLW Time 0 EVLW Time 6 EVLW Time 12 EVLW EVLW TIME 0 p=0.25 9.5 (8-12) 10 (8-13) 14 (13-15) 405 EVLW TIME (298-452) 6 *p=0.02 9 (8-10) Unclear if early EVLW added value beyond other early factors associated with PGD at 24 hours PaO 2 /FiO 2 time 0 11 (8-17) 262 12 (9-17)(232-408) EVLW TIME 12 *p=0.03 8 89 (8-12) (66-154) 9 (8-12) 13 (9-17) PGD time 0 72% - grade 1 21% - grade 2 6% - grade 3 38% - grade 1 50% - grade 2 13% - grade 3 20% - grade 1 20% - grade 2 60% - grade 3 PGD 24 HOURS GRADE 1 PGD GRADE 2 PGD GRADE 3 PGD

Factors Associated with PGD at 24 hours Adjusted Analysis (patient, donor, intraoperative, ICU factors) EVLW measured at 6 hours was independently associated with PGD grade at 24 hours VARIABLE IRR 95% CI p EVLW at 6 hours 1.06 1.01-1.12 0.02 PGD at admission 1.06 0.85-1.31 0.58 Intraoperative Support: ECMO CPB 1.17 1.05 0.99-1.40 0.68-1.62 0.06 0.82 APACHEII 1.05 1.01-1.08 0.012 Ischemic time 0.99 0.99-1.00 0.17 Age 1.00 0.99 1.01 0.169 Donor smoking 1.09 0.96-1.24 0.175 PVPI at 6 hours 1.07 0.94-1.23 0.30

EVLW between 0-12 hours 15 cc/kg Had High Specificity to Detect Grade 3 PGD at 24 hours High Specificity, Low Sensitivity of Early EVLW 15cc/kg in Predicting Grade 3 PGD at 24 hours EVLW time 0 >=15cc/kg SPECIFICITY SENSITIVITY ROC 89% 40% 0.81 ELWI time 6 >=14cc/kg 88% 50% 0.67 ELWI time 12 >=15cc/kg 93% 50% 0.70

Factors Independently Associated with Duration of MV Adjusted Analysis (patient, donor, intraoperative, ICU factors) EVLW measured at 12 hours was independently associated with duration of mechanical ventilation VARIABLE IRR 95% CI p EVLW at admission 0.98 0.86-1.12 0.78 EVLW at 12 hours 1.12 1.03-1.24 0.012 PGD at admission* PGD grade 2 PGD grade 3 PGD at 24 hours* PGD grade 2 PGD grade 3 0.47 0.50 0.22-1.01 0.11-2.10 0.06 0.34 3.32 7.44 1.60-6.91 2.67-20.7 0.001 <0.001 APACHE II 1.06 0.99-1.14 0.090 INTRAOP SUPPORT ECMO CPB 2.12 1.69 1.25-3.59 0.78-3.65 0.005 0.18 Age 1.02 0.98-1.05 0.46

EVLW between 0-12 hours 15 cc/kg Had High Specificity to Detect Prolonged Mechanical Vent High Specificity, Low Sensitivity of Early EVLW 15cc/kg in Predicting MV >48 hours EVLW time 0 >=15 cc/kg SPECIFICITY SENSITIVITY ROC 93% 23% 0.67 ELWI time 6 >=14 cc/kg 92% 25% 0.67 ELWI time 12 >=15 cc/kg 96% 18% 0.61

Discussion and Limitations EVLW was associated with PGD grade Early measurements of EVLW (6 hrs) and (12 hrs) independently associated with PGD at 24 hours and duration of mechanical ventilation EVLW cutpoint of 15 cc/kg between 0-12 hours has high specificity for grade 3 PGD at 24 hours and MV >48 hours Single center, small prospective observational study Unclear if marker of severity of illness or whether manipulating EVLW can modify outcome

Implications for ARDS EVLW is associated with ARDS severity Potential future utility in ARDS: Predicting who may be at risk of developing ARDS which may guide early initiation of protective therapies or future therapeutic strategies More meticulously guide safe restrictive fluid management strategy determined by thresholds of EVLW during fluid administration in ARDS Identify subcategories of patients within ARDS severities who may benefit from specific interventions/evaluate response to therapies

Conclusions EVLW is a promising method to quantify pulmonary edema EVLW may have important implications in the setting of ARDS and PGD in predicting severity and prognosis More data is needed to further confirm these findings and evaluate whether an EVLW-goal-directed algorithm can improve outcomes

Thank you Acknowledgements: John Granton Marcelo Cypel Alaa Mohamed Alyaa Elhazmi Bruno Ferreyro Jussi Tikkanen Ontario Thoracic Society Lung Transplant Surgical Fellows TGH ICU attending and nursing teams Lorenzo Del Sorbo Damon Scales Gordon Rubenfeld Eddy Fan Lung Transplant team

In patients admitted with PGD 1 Median EVLW time 0 was HIGHER in those who went onto develop grade 3 PGD at 24 hours compared to grade 1 PGD 1 ADMISSION PGD 1 24 H PGD 1 ADMISSION PGD 2 24H PGD 1 ADMISSION PGD 3 24H EVLW0 9 (7-12) 10 (8-13) 12 (11-13) PF0 441 (396-499) 414 (404-465) 395 (152-636) CVP0 5.5 (3.5-8.5) 8 (5-9) 6.5 (3.5-8.5)

Intrathoracic Thermal Volume = ITTV Double Indicator Dilution Technique cold indocyanine green dye Intrathoracic Blood Volume = ITBV EVLW = ITTV-ITBV Cumbersome Expensive Time consuming Technically challenging ELWI = EVLW indexed to PBW 32

Intrathoracic Thermal Volume = CO x MTT Pulmonary Thermal Volume = CO x DST Global End Diastolic Volume = ITTV - PTV PB V ITBV ITBV related to GEDV 1.25 x GEDI-28.4 33

3-7 cc/kg normal 10 cc/kg pulmonary edema Pulmonary Vascular Permeability Index: EVLW/PBV Lots of leak = HIGH Minimal leak = LOW 34

Limitations. Vascular Obstruction Hypoxic Vasoconstriction Positive End Expiratory Pressure Pleural Effusions Lung resection Low Cardiac Output States Mgt algorithms 35